This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Why Pharma should care about circular packaging – Futurity leading the way
Publications, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Product Solutions
Navigating the Development for Orally Inhaled and Nasal Drug Products
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions
Using Intranasal Delivery for Drug Repositioning: A Compelling Proposition for Lifecy...
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
The Potential and Challenge of Nasal Vaccination
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
